Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat
about
The HTLV-1 Tax interactomeHTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoterHIV-1 gene expression: lessons from provirus and non-integrated DNATetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathwaysViruses associated with human cancerDuplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulenceSpecific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complexInteraction of HTLV-1 Tax protein with calreticulin: implications for Tax nuclear export and secretion.Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway.Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.Evidence for NF-kappaB- and CBP-independent repression of p53's transcriptional activity by human T-cell leukemia virus type 1 Tax in mouse embryo and primary human fibroblasts.The high-affinity Sp1 binding site in the HTLV-1 promoter contributes to Tax-independent basal expressionMolecular mechanisms of cellular transformation by HTLV-1 Tax.Induction of lactoferrin gene expression in myeloid or mammary gland cells by human T-cell leukemia virus type 1 (HTLV-1) tax: implications for milk-borne transmission of HTLV-1.Versatile reporter systems show that transactivation by human T-cell leukemia virus type 1 Tax occurs independently of chromatin remodeling factor BRG1.Transcription regulatory complexes bind the human T-cell leukemia virus 5' and 3' long terminal repeats to control gene expression.Tax recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independentHuman T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZEviction of linker histone H1 by NAP-family histone chaperones enhances activated transcriptionTranscriptional and post-transcriptional gene regulation of HTLV-1.Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 PerspectiveUpregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein.Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates.Epigenetics, drugs of abuse, and the retroviral promoter.Seminal fluid enhances replication of human T-cell leukemia virus type 1: implications for sexual transmission.Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.The low viral production in trophoblastic cells is due to a high endocytic internalization of the human immunodeficiency virus type 1 and can be overcome by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-1.Tax-dependent displacement of nucleosomes during transcriptional activation of human T-cell leukemia virus type 1.A novel medium-throughput biological assay system for HTLV-1 infectivity and drug discovery.
P2860
Q21093224-B3B47505-7E61-4BC3-AC70-630BFDCF17D6Q21134702-3DED6AAD-C6C1-492F-B8FF-772201ED1546Q21245215-F9D853A0-83E5-4417-B382-3ACEC9D7175FQ24519068-7DBD6B3E-0D8A-49FB-B107-AB0F5962F690Q24653900-5B1BF424-38E0-402D-803A-AF8538967F31Q24672109-57D687EE-CEAA-4F94-BFC7-ED0F6E212BC1Q24798610-D799EE4F-7E4C-45A7-B0AC-150A0BF3DDFEQ30442529-A9F889FF-79C7-43E5-B3FD-90A1283D60E5Q33206633-8380A001-0BBE-427E-9086-1F6C60157A5AQ33709523-A6E0AEE5-4937-426E-9CAE-F8F6F3C7DE11Q33753132-32B599DC-AF47-4D35-8A58-B82ED9D4DB57Q33884079-8A27055E-D57B-452C-881A-EAF194A4D93DQ34333483-C8D95231-505F-4263-82FC-052BB889E66AQ34450092-7D123F34-6C19-4C14-B70D-B612ED31843AQ34717839-EB0F2B50-4787-4540-9694-2041D3A0F0DAQ35023685-B5148417-A8B3-4A77-BDA9-CB8842F44075Q35126347-20FE3BF7-53A2-4132-873F-F97E431E0EE2Q35148532-9AE4AE53-B582-49E2-A422-855D51579294Q35635372-4C91175D-0135-4A37-AC1E-37A6A5471F57Q35676690-17F74B9D-EFE7-416C-8C44-507FEF8EC956Q36022891-073B4F95-FBDC-4515-B725-C591438E84B8Q36254862-C3675252-E7A5-42AA-BE55-C455117426A2Q36417492-4664B807-089A-428E-9AAC-FE85D477E654Q37099844-42FB9B60-360C-4C82-B022-EF7A835B659CQ37333866-524BDAEB-E5BE-472A-BCC8-166C4636735DQ37425468-7D728F13-88DF-4A28-BBE9-17B3ED91C933Q37596955-48835EBB-B022-4689-9C59-B05C2E414DD4Q39239834-82E867B3-85EF-4D59-8EB4-8E99D129DE97Q39997604-F5C4C91A-85F5-4C24-87AB-C3784863B7C0Q40668413-82C4951D-5C6C-4824-8108-9121462A241CQ44748815-30A76B05-835E-422B-A738-5D0CD5627E49Q47100549-8069893E-E26E-4B01-AED6-08ACCAADB5DA
P2860
Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Differential requirements for ...... us type 1 long terminal repeat
@ast
Differential requirements for ...... us type 1 long terminal repeat
@en
Differential requirements for ...... us type 1 long terminal repeat
@nl
type
label
Differential requirements for ...... us type 1 long terminal repeat
@ast
Differential requirements for ...... us type 1 long terminal repeat
@en
Differential requirements for ...... us type 1 long terminal repeat
@nl
prefLabel
Differential requirements for ...... us type 1 long terminal repeat
@ast
Differential requirements for ...... us type 1 long terminal repeat
@en
Differential requirements for ...... us type 1 long terminal repeat
@nl
P2860
P1433
P1476
Differential requirements for ...... us type 1 long terminal repeat
@en
P2093
Kuan-Teh Jeang
Masahiko Okada
P2860
P304
12564-12573
P356
10.1128/JVI.76.24.12564-12573.2002
P407
P577
2002-12-01T00:00:00Z